Navigation Links
Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures
Date:12/7/2009

Pollogen received ANVISA approval to market the TriPollar Technology- the most advanced 3rd generation Radio Frequency solution for facial and body contouring. TriPollar anti-aging products have been clinically proven the world over to be safe and effective on all skin types. The treatment is completely painless and non-invasive and patients enjoy visible results from the very 1st treatment. Long term results are achieved by undergoing a series of treatments.

Tel Aviv, Israel (PRWEB) December 1, 2009 -- Pollogen Ltd. announced today the receipt of ANVISA clearance to market their proprietary TriPollar based aesthetic products in Brazil. ANVISA (Agencia Nacional de Vigilancia Sanitaria) is a Brazilian national health surveillance and regulatory agency charged with clearing all applications to market medical devices in Brazil.

Breakthrough TriPollar technology, the most advanced 3rd generation Radio Frequency solution for facial and body contouring, is distributed exclusively by Pollogen's Brazilian partner, Sao Paulo based HV Com. Imp e Exp. Ltda.
TriPollar technology has been clinically and histopathologically proven to tighten the skin, reduce cellulite and stretch marks, as well as contour the body. The safe and effective anti aging TriPollar treatment is completely non-invasive, and is carried out in an office based environment. Results are visible immediately following the first treatment and long term results are achieved by undergoing a series of treatments. Thousands of patients worldwide have enjoyed the simple "lunch time" treatment and reported a painless and pleasant experience.

"We are delighted to introduce TriPollar technology to the Brazilian market. Brazil's aesthetic market is one of the fastest growing markets in the world and both aesthetic professionals and patients are constantly seeking the latest anti aging technologies. TriPollar based products have proven to be effective in treating a wide variety of aesthetic needs and we are excited to be offering TriPollar based solutions in Brazil" said HV Com's CEO, Mr. Newton Martins.

Pollogen's CEO, Dr. Zion Azar stated: "The Brazilian market is a significant milestone for Pollogen and we are delighted to have received the ANVISA approval. Pollogen's global presence now covers over 60 countries and we are delighted to be in the forefront of aesthetic solutions that offer a non-surgical alternative that yields both immediate and long term anti-aging results."

About Pollogen:
Pollogen Ltd. develops, manufactures and markets professional medical aesthetic devices, powered by the TriPollar 3rd generation Radio Frequency (RF) technology. Invented and perfected by Pollogen, proprietary TriPollar technology powers a full line of clinically-proven, non-invasive and non-surgical treatment platforms for wrinkles, cellulite, circumference reduction and skin tightening. The flagship aesthetic devices, apollo™ and regen™ offer customers clinically-proven, safe and effective anti-aging beauty treatments that deliver immediate and long-lasting results. To learn more, please visit the Pollogen website at www.pollogen.com

Contact:
Name: Abigail Marks
Tel: + 972-54-244-5807

###

Read the full story at http://www.prweb.com/releases/pollogen/anti-aging/prweb3281804.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Breakthrough in industrial-scale nanotube processing
2. Lupus Research Institute: Benlysta(TM) Trial Results in an Historic Research Breakthrough and Victory for People With Lupus
3. Global Med Technologies(R) Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product
4. Simbionix USA Corporations Innovative Development Division Releases Two New Breakthrough Technologies
5. New Collaborations and Breakthrough Advancements in RNA-Based Drug Development Programs Lead Santaris Pharma A/S to Establish US Operations
6. Tetraphase Presents Study Results for Novel Classes of Antibiotics from its Breakthrough Synthetic Chemistry Platform at ICAAC 2009
7. Aurora Biofuels Breakthrough Doubles CO2 Uptake and Fuel Production
8. Research breakthrough will lead to more accurate weather forecasts
9. OMT announces a breakthrough in the development of a novel human antibody platform
10. New drugs faster from natural compounds: A UC San Diego breakthrough
11. Expanding Indianas Breakthroughs in Health Information Technology (Exibhit Indiana): Initiative to Advance the States Health IT National Leadership and Assets Launched to Bring More Awareness to Sector
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 
(Date:1/19/2017)... and GAITHERSBURG, Md. , ... PIP) and Altimmune, Inc., a privately-held immunotherapeutics company ... a definitive agreement for the merger of PharmAthene ... investors include Novartis Venture Fund, HealthCap, Truffle Capital ... a fully-integrated and diversified immunotherapeutics company with four ...
(Date:1/19/2017)... (PRWEB) , ... January 18, 2017 , ... ... for tech innovators, engineers, and scientists from around the world, was today awarded ... The awards program is based entirely on merit and decided upon by a ...
(Date:1/19/2017)... 2017  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW Bio"), ... for operable and inoperable solid tumor cancers, announced today ... of NW Bio, will present at the Phacilitate Immunotherapy ... Hyatt Regency Hotel in Miami, Florida ... entitled "New Therapeutic Approaches – Expanding the Reach of ...
(Date:1/18/2017)... According to a new market research report "In situ Hybridization Market ... User (Molecular Diagnostic Laboratories, Academic and Research Institutions) - Global Forecast to 2021" ... 2021 from USD 557.1 Million in 2016, growing at a CAGR of 5.8%. ... ... MarketsandMarkets Logo ...
Breaking Biology Technology:
(Date:1/12/2017)... NEW YORK , Jan. 12, 2017  New research ... around the office of the future.  1,000 participants were simply ... last three months which we may consider standard issue.  Insights ... office of 2017 were also gathered from futurists and industry ... and Dr. James Canton .  Some ...
(Date:1/11/2017)... DES MOINES, Iowa , Jan. 11, 2017 /PRNewswire/ ... another industry first with the release of its patent-pending ... to quickly and reliably perform calibrations, securely upload data ... more flexibility for the customer. "Fighting drunk ... not only for the public at large, but also ...
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, ... studies in healthy volunteers of a novel calcium ... treat acute pancreatitis. Acute pancreatitis, ... a mild disorder, but can be very serious.  In ... and sepsis, where extended hospital stays, time in ...
Breaking Biology News(10 mins):